Literature DB >> 24630832

Celecoxib and ion channels: a story of unexpected discoveries.

Roman V Frolov1, Satpal Singh2.   

Abstract

Celecoxib (Celebrex), a highly popular selective inhibitor of cyclooxygenase-2, can modulate ion channels and alter functioning of neurons and myocytes at clinically relevant concentrations independently of cyclooxygenase inhibition. In experimental systems varying from Drosophila to primary mammalian and human cell lines, celecoxib inhibits many voltage-activated Na(+), Ca(2+), and K(+) channels, including NaV1.5, L- and T-type Ca(2+) channels, KV1.5, KV2.1, KV4.3, KV7.1, KV11.1 (hERG), while stimulating other K(+) channels-KV7.2-5 and, possibly, KV11.1 (hERG) channels under certain conditions. In this review, we summarize the information currently available on the effects of celecoxib on ion channels, examine mechanistic aspects of drug action and the concomitant changes at the cellular and organ levels, and discuss these findings in the therapeutic context.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  COX-2 inhibitor; Calcium channel; Celecoxib; Potassium channel; Sodium channel

Mesh:

Substances:

Year:  2014        PMID: 24630832     DOI: 10.1016/j.ejphar.2014.02.032

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

1.  Evidence of more ion channels inhibited by celecoxib: KV1.3 and L-type Ca(2+) channels.

Authors:  Roman V Frolov; Satpal Singh
Journal:  BMC Res Notes       Date:  2015-03-01

2.  Investigation of cyclooxygenase and signaling pathways involved in human platelet aggregation mediated by synergistic interaction of various agonists.

Authors:  Nadia Khan; Ahsana Dar Farooq; Bassem Sadek
Journal:  Drug Des Devel Ther       Date:  2015-07-06       Impact factor: 4.162

3.  Celecoxib increases EGF signaling in colon tumor associated fibroblasts, modulating EGFR expression and degradation.

Authors:  Roberta Venè; Francesca Tosetti; Simona Minghelli; Alessandro Poggi; Nicoletta Ferrari; Roberto Benelli
Journal:  Oncotarget       Date:  2015-05-20

Review 4.  Impact of the prolymphangiogenic crosstalk in the tumor microenvironment on lymphatic cancer metastasis.

Authors:  Simona L Schlereth; Nasrin Refaian; Sandra Iden; Claus Cursiefen; Ludwig M Heindl
Journal:  Biomed Res Int       Date:  2014-09-01       Impact factor: 3.411

5.  Prediction of the potency of mammalian cyclooxygenase inhibitors with ensemble proteochemometric modeling.

Authors:  Isidro Cortes-Ciriano; Daniel S Murrell; Gerard Jp van Westen; Andreas Bender; Thérèse E Malliavin
Journal:  J Cheminform       Date:  2015-01-16       Impact factor: 5.514

Review 6.  Potassium Channelopathies and Gastrointestinal Ulceration.

Authors:  Jaeyong Han; Seung Hun Lee; Gerhard Giebisch; Tong Wang
Journal:  Gut Liver       Date:  2016-11-15       Impact factor: 4.519

7.  Definition of hidden drug cardiotoxicity: paradigm change in cardiac safety testing and its clinical implications.

Authors:  Péter Ferdinandy; István Baczkó; Péter Bencsik; Zoltán Giricz; Anikó Görbe; Pál Pacher; Zoltán V Varga; András Varró; Rainer Schulz
Journal:  Eur Heart J       Date:  2019-06-07       Impact factor: 29.983

8.  SP6616 as a new Kv2.1 channel inhibitor efficiently promotes β-cell survival involving both PKC/Erk1/2 and CaM/PI3K/Akt signaling pathways.

Authors:  T T Zhou; L L Quan; L P Chen; T Du; K X Sun; J C Zhang; L Yu; Y Li; P Wan; L L Chen; B H Jiang; L H Hu; J Chen; X Shen
Journal:  Cell Death Dis       Date:  2016-05-05       Impact factor: 8.469

9.  On the role of transient depolarization-activated K+ current in microvillar photoreceptors.

Authors:  Roman V Frolov
Journal:  J Gen Physiol       Date:  2018-07-26       Impact factor: 4.086

Review 10.  Challenges Faced with Small Molecular Modulators of Potassium Current Channel Isoform Kv1.5.

Authors:  Zefeng Zhao; Songsong Ruan; Xiaoming Ma; Qian Feng; Zhuosong Xie; Zhuang Nie; Peinan Fan; Mingcheng Qian; Xirui He; Shaoping Wu; Yongmin Zhang; Xiaohui Zheng
Journal:  Biomolecules       Date:  2019-12-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.